APIの世界市場レポート2024-2030
英文タイトル: Global Active Pharmaceutical Ingredients (API) Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=150円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=150円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は、APIの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にAPI市場を分類しています。本レポートでは世界のAPI市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Teva、Viatris、DSM、Aurobindo Pharma、Aspen、Novartis、BASF、Pfizer、Huahai Pharmaceutical、Hisun Pharmaceutical、Sun Pharmaceutical Industries、Zhejiang Medicine、Dr. Reddy’s Laboratories、Zhejiang NHU、Apeloa Pharmaceutical、NCPC、United Laboratories、Shandong Xinhua Pharmaceutical、CSPC、Harbin Pharmaceutical、LKPC
レポートはAPIの主要生産者を調査し、主要地域や国の消費状況も提供します。APIの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。
2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。タイプ別市場セグメント:
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別(地域レベル、国レベル)のAPI生産量、成長率、市場シェアを調査している。
Synthetic APIs
Biotech APIs
用途別の市場セグメント:
Tablet
Injection
Capsule
Others
本レポートの詳細内容
本レポートは、世界のAPI市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてAPI市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
二. 消費面では、APIの売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。
三.主要メーカーのAPI売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のAPI市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。
四.本APIのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章の概要第1章:APIのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(2019~2030)
第2章: APIの世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(2019~2030)
第3章:世界、地域、国レベルにおけるAPIの売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(2019~2030)
第4章APIメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(2019~2024)
第5章:APIの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(2019~2030)
第8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(2019~2030)
第9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(2019~2030)
第10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(2019~2030)
第11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(2019~2030)
第12章:APIの主要メーカーの概要を提供し、製品の説明と仕様、APIの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(2019~2024)
第13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章:APIの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章:レポートの要点と結論。
概要
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug. The global Active Pharmaceutical Ingredients (API) market is projected to grow from US$ 181840 million in 2024 to US$ 269850 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period. The Active Pharmaceutical Ingredients (API) market is driven by several key factors, with one of the main drivers being the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. As the global population ages, there is a growing demand for medications to treat these long-term conditions, which in turn drives the demand for high-quality APIs used in drug manufacturing. Furthermore, advancements in biotechnology and the growing trend toward personalized medicine have expanded the range of APIs being developed, particularly in complex biologics.Another major driver is the rise in generic drug production. With the patent expirations of many blockbuster drugs, generic manufacturers are capitalizing on opportunities to produce cheaper alternatives, which require cost-effective, high-quality APIs. Regulatory support for generics, particularly in developing regions, has further spurred the growth of the API market, as governments push for more affordable healthcare options.Despite these growth drivers, the API market faces several challenges. One of the most significant is the increasing regulatory scrutiny and the need for compliance with stringent quality standards, especially for APIs manufactured in developing countries. Additionally, the market is highly competitive, and manufacturers must deal with fluctuating raw material costs, supply chain disruptions, and price pressures. This combination of regulatory and economic hurdles requires significant investment in infrastructure and innovation to maintain competitiveness in the API landscape. In terms of production side, this report researches the Active Pharmaceutical Ingredients (API) production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030. In terms of consumption side, this report focuses on the sales of Active Pharmaceutical Ingredients (API) by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030. This report presents an overview of global market for Active Pharmaceutical Ingredients (API), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Active Pharmaceutical Ingredients (API), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Active Pharmaceutical Ingredients (API), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Active Pharmaceutical Ingredients (API) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Active Pharmaceutical Ingredients (API) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Active Pharmaceutical Ingredients (API) sales, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Teva, Viatris, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer, Huahai Pharmaceutical, Hisun Pharmaceutical, etc. Market Segmentation By Company Teva Viatris DSM Aurobindo Pharma Aspen Novartis BASF Pfizer Huahai Pharmaceutical Hisun Pharmaceutical Sun Pharmaceutical Industries Zhejiang Medicine Dr. Reddy’s Laboratories Zhejiang NHU Apeloa Pharmaceutical NCPC United Laboratories Shandong Xinhua Pharmaceutical CSPC Harbin Pharmaceutical LKPC Segment by Type Synthetic APIs Biotech APIs Segment by Application Tablet Injection Capsule Others Production by Region North America Europe China Japan India Sales by Region US & Canada U.S. Canada China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia Europe Germany France U.K. Italy Russia Middle East, Africa, Latin America Brazil Mexico Turkey Israel Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Active Pharmaceutical Ingredients (API) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years. Chapter 3: Sales (consumption), revenue of Active Pharmaceutical Ingredients (API) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 4: Detailed analysis of Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment. Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment. Chapter 9: China by Type, and by Application, sales, and revenue for each segment. Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment. Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment. Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Active Pharmaceutical Ingredients (API) sales, revenue, price, gross margin, and recent development, etc. Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers. Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 15: The main points and conclusions of the report.
総目録
1 Study Coverage
1.1 Active Pharmaceutical Ingredients (API) Product Introduction
1.2 Market by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Market by Application
1.3.1 Global Active Pharmaceutical Ingredients (API) Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Tablet
1.3.3 Injection
1.3.4 Capsule
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Active Pharmaceutical Ingredients (API) Production
2.1 Global Active Pharmaceutical Ingredients (API) Production Capacity (2019-2030)
2.2 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019 VS 2023 VS 2030
2.3 Global Active Pharmaceutical Ingredients (API) Production by Region
2.3.1 Global Active Pharmaceutical Ingredients (API) Historic Production by Region (2019-2024)
2.3.2 Global Active Pharmaceutical Ingredients (API) Forecasted Production by Region (2025-2030)
2.3.3 Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 India
3 Executive Summary
3.1 Global Active Pharmaceutical Ingredients (API) Revenue Estimates and Forecasts 2019-2030
3.2 Global Active Pharmaceutical Ingredients (API) Revenue by Region
3.2.1 Global Active Pharmaceutical Ingredients (API) Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Active Pharmaceutical Ingredients (API) Revenue by Region (2019-2024)
3.2.3 Global Active Pharmaceutical Ingredients (API) Revenue by Region (2025-2030)
3.2.4 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2019-2030)
3.3 Global Active Pharmaceutical Ingredients (API) Sales Estimates and Forecasts 2019-2030
3.4 Global Active Pharmaceutical Ingredients (API) Sales by Region
3.4.1 Global Active Pharmaceutical Ingredients (API) Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Active Pharmaceutical Ingredients (API) Sales by Region (2019-2024)
3.4.3 Global Active Pharmaceutical Ingredients (API) Sales by Region (2025-2030)
3.4.4 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers
4.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2019-2024)
4.1.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Active Pharmaceutical Ingredients (API) in 2023
4.2 Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers
4.2.1 Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2019-2024)
4.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients (API) Revenue in 2023
4.3 Global Active Pharmaceutical Ingredients (API) Sales Price by Manufacturers (2019-2024)
4.4 Global Key Players of Active Pharmaceutical Ingredients (API), Industry Ranking, 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Product Offered and Application
4.8 Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Active Pharmaceutical Ingredients (API) Sales by Type
5.1.1 Global Active Pharmaceutical Ingredients (API) Historical Sales by Type (2019-2024)
5.1.2 Global Active Pharmaceutical Ingredients (API) Forecasted Sales by Type (2025-2030)
5.1.3 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type
5.2.1 Global Active Pharmaceutical Ingredients (API) Historical Revenue by Type (2019-2024)
5.2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Revenue by Type (2025-2030)
5.2.3 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type
5.3.1 Global Active Pharmaceutical Ingredients (API) Price by Type (2019-2024)
5.3.2 Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Active Pharmaceutical Ingredients (API) Sales by Application
6.1.1 Global Active Pharmaceutical Ingredients (API) Historical Sales by Application (2019-2024)
6.1.2 Global Active Pharmaceutical Ingredients (API) Forecasted Sales by Application (2025-2030)
6.1.3 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030)
6.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application
6.2.1 Global Active Pharmaceutical Ingredients (API) Historical Revenue by Application (2019-2024)
6.2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Revenue by Application (2025-2030)
6.2.3 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030)
6.3 Global Active Pharmaceutical Ingredients (API) Price by Application
6.3.1 Global Active Pharmaceutical Ingredients (API) Price by Application (2019-2024)
6.3.2 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Active Pharmaceutical Ingredients (API) Market Size by Type
7.1.1 US & Canada Active Pharmaceutical Ingredients (API) Sales by Type (2019-2030)
7.1.2 US & Canada Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2030)
7.2 US & Canada Active Pharmaceutical Ingredients (API) Market Size by Application
7.2.1 US & Canada Active Pharmaceutical Ingredients (API) Sales by Application (2019-2030)
7.2.2 US & Canada Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2030)
7.3 US & Canada Active Pharmaceutical Ingredients (API) Market Size by Country
7.3.1 US & Canada Active Pharmaceutical Ingredients (API) Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2030)
7.3.3 US & Canada Active Pharmaceutical Ingredients (API) Sales by Country (2019-2030)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Active Pharmaceutical Ingredients (API) Market Size by Type
8.1.1 Europe Active Pharmaceutical Ingredients (API) Sales by Type (2019-2030)
8.1.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2030)
8.2 Europe Active Pharmaceutical Ingredients (API) Market Size by Application
8.2.1 Europe Active Pharmaceutical Ingredients (API) Sales by Application (2019-2030)
8.2.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2030)
8.3 Europe Active Pharmaceutical Ingredients (API) Market Size by Country
8.3.1 Europe Active Pharmaceutical Ingredients (API) Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Active Pharmaceutical Ingredients (API) Sales by Country (2019-2030)
8.3.3 Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Active Pharmaceutical Ingredients (API) Market Size by Type
9.1.1 China Active Pharmaceutical Ingredients (API) Sales by Type (2019-2030)
9.1.2 China Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2030)
9.2 China Active Pharmaceutical Ingredients (API) Market Size by Application
9.2.1 China Active Pharmaceutical Ingredients (API) Sales by Application (2019-2030)
9.2.2 China Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Active Pharmaceutical Ingredients (API) Market Size by Type
10.1.1 Asia Active Pharmaceutical Ingredients (API) Sales by Type (2019-2030)
10.1.2 Asia Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2030)
10.2 Asia Active Pharmaceutical Ingredients (API) Market Size by Application
10.2.1 Asia Active Pharmaceutical Ingredients (API) Sales by Application (2019-2030)
10.2.2 Asia Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2030)
10.3 Asia Active Pharmaceutical Ingredients (API) Market Size by Region
10.3.1 Asia Active Pharmaceutical Ingredients (API) Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Active Pharmaceutical Ingredients (API) Revenue by Region (2019-2030)
10.3.3 Asia Active Pharmaceutical Ingredients (API) Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Market Size by Type
11.1.1 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Market Size by Application
11.2.1 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Market Size by Country
11.3.1 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Overview
12.1.3 Teva Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Teva Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Teva Recent Developments
12.2 Viatris
12.2.1 Viatris Corporation Information
12.2.2 Viatris Overview
12.2.3 Viatris Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Viatris Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Viatris Recent Developments
12.3 DSM
12.3.1 DSM Corporation Information
12.3.2 DSM Overview
12.3.3 DSM Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 DSM Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 DSM Recent Developments
12.4 Aurobindo Pharma
12.4.1 Aurobindo Pharma Corporation Information
12.4.2 Aurobindo Pharma Overview
12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Aurobindo Pharma Recent Developments
12.5 Aspen
12.5.1 Aspen Corporation Information
12.5.2 Aspen Overview
12.5.3 Aspen Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Aspen Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Aspen Recent Developments
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Overview
12.6.3 Novartis Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Novartis Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Novartis Recent Developments
12.7 BASF
12.7.1 BASF Corporation Information
12.7.2 BASF Overview
12.7.3 BASF Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 BASF Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 BASF Recent Developments
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Overview
12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Pfizer Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Pfizer Recent Developments
12.9 Huahai Pharmaceutical
12.9.1 Huahai Pharmaceutical Corporation Information
12.9.2 Huahai Pharmaceutical Overview
12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Huahai Pharmaceutical Recent Developments
12.10 Hisun Pharmaceutical
12.10.1 Hisun Pharmaceutical Corporation Information
12.10.2 Hisun Pharmaceutical Overview
12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Hisun Pharmaceutical Recent Developments
12.11 Sun Pharmaceutical Industries
12.11.1 Sun Pharmaceutical Industries Corporation Information
12.11.2 Sun Pharmaceutical Industries Overview
12.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Sun Pharmaceutical Industries Recent Developments
12.12 Zhejiang Medicine
12.12.1 Zhejiang Medicine Corporation Information
12.12.2 Zhejiang Medicine Overview
12.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Zhejiang Medicine Recent Developments
12.13 Dr. Reddy’s Laboratories
12.13.1 Dr. Reddy’s Laboratories Corporation Information
12.13.2 Dr. Reddy’s Laboratories Overview
12.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Dr. Reddy’s Laboratories Recent Developments
12.14 Zhejiang NHU
12.14.1 Zhejiang NHU Corporation Information
12.14.2 Zhejiang NHU Overview
12.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Zhejiang NHU Recent Developments
12.15 Apeloa Pharmaceutical
12.15.1 Apeloa Pharmaceutical Corporation Information
12.15.2 Apeloa Pharmaceutical Overview
12.15.3 Apeloa Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.15.4 Apeloa Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Apeloa Pharmaceutical Recent Developments
12.16 NCPC
12.16.1 NCPC Corporation Information
12.16.2 NCPC Overview
12.16.3 NCPC Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.16.4 NCPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 NCPC Recent Developments
12.17 United Laboratories
12.17.1 United Laboratories Corporation Information
12.17.2 United Laboratories Overview
12.17.3 United Laboratories Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.17.4 United Laboratories Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 United Laboratories Recent Developments
12.18 Shandong Xinhua Pharmaceutical
12.18.1 Shandong Xinhua Pharmaceutical Corporation Information
12.18.2 Shandong Xinhua Pharmaceutical Overview
12.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Shandong Xinhua Pharmaceutical Recent Developments
12.19 CSPC
12.19.1 CSPC Corporation Information
12.19.2 CSPC Overview
12.19.3 CSPC Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.19.4 CSPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 CSPC Recent Developments
12.20 Harbin Pharmaceutical
12.20.1 Harbin Pharmaceutical Corporation Information
12.20.2 Harbin Pharmaceutical Overview
12.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Harbin Pharmaceutical Recent Developments
12.21 LKPC
12.21.1 LKPC Corporation Information
12.21.2 LKPC Overview
12.21.3 LKPC Active Pharmaceutical Ingredients (API) Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.21.4 LKPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
12.21.5 LKPC Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Active Pharmaceutical Ingredients (API) Industry Chain Analysis
13.2 Active Pharmaceutical Ingredients (API) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Active Pharmaceutical Ingredients (API) Production Mode & Process
13.4 Active Pharmaceutical Ingredients (API) Sales and Marketing
13.4.1 Active Pharmaceutical Ingredients (API) Sales Channels
13.4.2 Active Pharmaceutical Ingredients (API) Distributors
13.5 Active Pharmaceutical Ingredients (API) Customers
14 Active Pharmaceutical Ingredients (API) Market Dynamics
14.1 Active Pharmaceutical Ingredients (API) Industry Trends
14.2 Active Pharmaceutical Ingredients (API) Market Drivers
14.3 Active Pharmaceutical Ingredients (API) Market Challenges
14.4 Active Pharmaceutical Ingredients (API) Market Restraints
15 Key Findings in the Global Active Pharmaceutical Ingredients (API) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
表と図のリスト
List of Tables Table 1. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Table 2. Key Manufacturers of Synthetic APIs Table 3. Key Manufacturers of Biotech APIs Table 4. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Table 5. Global Active Pharmaceutical Ingredients (API) Production Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons) Table 6. Global Active Pharmaceutical Ingredients (API) Production by Region (2019-2024) & (Tons) Table 7. Global Active Pharmaceutical Ingredients (API) Production by Region (2025-2030) & (Tons) Table 8. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2019-2024) Table 9. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2025-2030) Table 10. Global Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 11. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2019-2024) & (US$ Million) Table 12. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2025-2030) & (US$ Million) Table 13. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2019-2024) Table 14. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2025-2030) Table 15. Global Active Pharmaceutical Ingredients (API) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons) Table 16. Global Active Pharmaceutical Ingredients (API) Sales by Region (2019-2024) & (Tons) Table 17. Global Active Pharmaceutical Ingredients (API) Sales by Region (2025-2030) & (Tons) Table 18. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2019-2024) Table 19. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2025-2030) Table 20. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2019-2024) & (Tons) Table 21. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2019-2024) Table 22. Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2019-2024) & (US$ Million) Table 23. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2019-2024) Table 24. Active Pharmaceutical Ingredients (API) Price by Manufacturers (2019-2024) & (USD/Ton) Table 25. Global Key Players of Active Pharmaceutical Ingredients (API), Industry Ranking, 2022 VS 2023 Table 26. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 27. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2023) Table 28. Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Manufacturing Base Distribution and Headquarters Table 29. Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Product Offered and Application Table 30. Global Key Manufacturers of Active Pharmaceutical Ingredients (API), Date of Enter into This Industry Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons) Table 33. Global Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons) Table 34. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2019-2024) Table 35. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2025-2030) Table 36. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million) Table 37. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million) Table 38. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2019-2024) Table 39. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2025-2030) Table 40. Active Pharmaceutical Ingredients (API) Price by Type (2019-2024) & (USD/Ton) Table 41. Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2025-2030) & (USD/Ton) Table 42. Global Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons) Table 43. Global Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons) Table 44. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2019-2024) Table 45. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2025-2030) Table 46. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million) Table 47. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million) Table 48. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2019-2024) Table 49. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2025-2030) Table 50. Active Pharmaceutical Ingredients (API) Price by Application (2019-2024) & (USD/Ton) Table 51. Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2025-2030) & (USD/Ton) Table 52. US & Canada Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons) Table 53. US & Canada Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons) Table 54. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million) Table 55. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million) Table 56. US & Canada Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons) Table 57. US & Canada Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons) Table 58. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million) Table 59. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million) Table 60. US & Canada Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 61. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2024) & (US$ Million) Table 62. US & Canada Active Pharmaceutical Ingredients (API) Revenue by Country (2025-2030) & (US$ Million) Table 63. US & Canada Active Pharmaceutical Ingredients (API) Sales by Country (2019-2024) & (Tons) Table 64. US & Canada Active Pharmaceutical Ingredients (API) Sales by Country (2025-2030) & (Tons) Table 65. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons) Table 66. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons) Table 67. Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million) Table 68. Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million) Table 69. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons) Table 70. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons) Table 71. Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million) Table 72. Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million) Table 73. Europe Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 74. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2019-2024) & (Tons) Table 75. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2025-2030) & (Tons) Table 76. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2024) & (US$ Million) Table 77. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2025-2030) & (US$ Million) Table 78. China Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons) Table 79. China Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons) Table 80. China Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million) Table 81. China Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million) Table 82. China Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons) Table 83. China Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons) Table 84. China Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million) Table 85. China Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million) Table 86. Asia Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons) Table 87. Asia Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons) Table 88. Asia Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million) Table 89. Asia Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million) Table 90. Asia Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons) Table 91. Asia Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons) Table 92. Asia Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million) Table 93. Asia Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million) Table 94. Asia Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 95. Asia Active Pharmaceutical Ingredients (API) Revenue by Region (2019-2024) & (US$ Million) Table 96. Asia Active Pharmaceutical Ingredients (API) Revenue by Region (2025-2030) & (US$ Million) Table 97. Asia Active Pharmaceutical Ingredients (API) Sales by Region (2019-2024) & (Tons) Table 98. Asia Active Pharmaceutical Ingredients (API) Sales by Region (2025-2030) & (Tons) Table 99. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2019-2024) & (Tons) Table 100. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2025-2030) & (Tons) Table 101. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2019-2024) & (US$ Million) Table 102. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2025-2030) & (US$ Million) Table 103. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2019-2024) & (Tons) Table 104. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2025-2030) & (Tons) Table 105. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2019-2024) & (US$ Million) Table 106. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2025-2030) & (US$ Million) Table 107. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 108. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2019-2024) & (US$ Million) Table 109. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2025-2030) & (US$ Million) Table 110. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2019-2024) & (Tons) Table 111. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2025-2030) & (Tons) Table 112. Teva Corporation Information Table 113. Teva Description and Major Businesses Table 114. Teva Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 115. Teva Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 116. Teva Recent Developments Table 117. Viatris Corporation Information Table 118. Viatris Description and Major Businesses Table 119. Viatris Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 120. Viatris Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 121. Viatris Recent Developments Table 122. DSM Corporation Information Table 123. DSM Description and Major Businesses Table 124. DSM Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 125. DSM Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 126. DSM Recent Developments Table 127. Aurobindo Pharma Corporation Information Table 128. Aurobindo Pharma Description and Major Businesses Table 129. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 130. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 131. Aurobindo Pharma Recent Developments Table 132. Aspen Corporation Information Table 133. Aspen Description and Major Businesses Table 134. Aspen Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 135. Aspen Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 136. Aspen Recent Developments Table 137. Novartis Corporation Information Table 138. Novartis Description and Major Businesses Table 139. Novartis Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 140. Novartis Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 141. Novartis Recent Developments Table 142. BASF Corporation Information Table 143. BASF Description and Major Businesses Table 144. BASF Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 145. BASF Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 146. BASF Recent Developments Table 147. Pfizer Corporation Information Table 148. Pfizer Description and Major Businesses Table 149. Pfizer Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 150. Pfizer Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 151. Pfizer Recent Developments Table 152. Huahai Pharmaceutical Corporation Information Table 153. Huahai Pharmaceutical Description and Major Businesses Table 154. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 155. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 156. Huahai Pharmaceutical Recent Developments Table 157. Hisun Pharmaceutical Corporation Information Table 158. Hisun Pharmaceutical Description and Major Businesses Table 159. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 160. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 161. Hisun Pharmaceutical Recent Developments Table 162. Sun Pharmaceutical Industries Corporation Information Table 163. Sun Pharmaceutical Industries Description and Major Businesses Table 164. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 165. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 166. Sun Pharmaceutical Industries Recent Developments Table 167. Zhejiang Medicine Corporation Information Table 168. Zhejiang Medicine Description and Major Businesses Table 169. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 170. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 171. Zhejiang Medicine Recent Developments Table 172. Dr. Reddy’s Laboratories Corporation Information Table 173. Dr. Reddy’s Laboratories Description and Major Businesses Table 174. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 175. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 176. Dr. Reddy’s Laboratories Recent Developments Table 177. Zhejiang NHU Corporation Information Table 178. Zhejiang NHU Description and Major Businesses Table 179. Zhejiang NHU Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 180. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 181. Zhejiang NHU Recent Developments Table 182. Apeloa Pharmaceutical Corporation Information Table 183. Apeloa Pharmaceutical Description and Major Businesses Table 184. Apeloa Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 185. Apeloa Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 186. Apeloa Pharmaceutical Recent Developments Table 187. NCPC Corporation Information Table 188. NCPC Description and Major Businesses Table 189. NCPC Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 190. NCPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 191. NCPC Recent Developments Table 192. United Laboratories Corporation Information Table 193. United Laboratories Description and Major Businesses Table 194. United Laboratories Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 195. United Laboratories Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 196. United Laboratories Recent Developments Table 197. Shandong Xinhua Pharmaceutical Corporation Information Table 198. Shandong Xinhua Pharmaceutical Description and Major Businesses Table 199. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 200. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 201. Shandong Xinhua Pharmaceutical Recent Developments Table 202. CSPC Corporation Information Table 203. CSPC Description and Major Businesses Table 204. CSPC Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 205. CSPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 206. CSPC Recent Developments Table 207. Harbin Pharmaceutical Corporation Information Table 208. Harbin Pharmaceutical Description and Major Businesses Table 209. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 210. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 211. Harbin Pharmaceutical Recent Developments Table 212. LKPC Corporation Information Table 213. LKPC Description and Major Businesses Table 214. LKPC Active Pharmaceutical Ingredients (API) Capacity, Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024) Table 215. LKPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications Table 216. LKPC Recent Developments Table 217. Key Raw Materials Lists Table 218. Raw Materials Key Suppliers Lists Table 219. Active Pharmaceutical Ingredients (API) Distributors List Table 220. Active Pharmaceutical Ingredients (API) Customers List Table 221. Active Pharmaceutical Ingredients (API) Market Trends Table 222. Active Pharmaceutical Ingredients (API) Market Drivers Table 223. Active Pharmaceutical Ingredients (API) Market Challenges Table 224. Active Pharmaceutical Ingredients (API) Market Restraints Table 225. Research Programs/Design for This Report Table 226. Key Data Information from Secondary Sources Table 227. Key Data Information from Primary Sources List of Figures Figure 1. Active Pharmaceutical Ingredients (API) Product Picture Figure 2. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Active Pharmaceutical Ingredients (API) Market Share by Type: 2023 & 2030 Figure 4. Synthetic APIs Product Picture Figure 5. Biotech APIs Product Picture Figure 6. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 7. Global Active Pharmaceutical Ingredients (API) Market Share by Application in 2024 & 2030 Figure 8. Tablet Figure 9. Injection Figure 10. Capsule Figure 11. Others Figure 12. Active Pharmaceutical Ingredients (API) Report Years Considered Figure 13. Global Active Pharmaceutical Ingredients (API) Capacity, Production and Utilization (2019-2030) & (Tons) Figure 14. Global Active Pharmaceutical Ingredients (API) Production by Region: 2019 VS 2023 VS 2030 (Tons) Figure 15. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region in Percentage: 2023 Versus 2030 Figure 16. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2019-2030) Figure 17. Active Pharmaceutical Ingredients (API) Production Growth Rate in North America (2019-2030) & (Tons) Figure 18. Active Pharmaceutical Ingredients (API) Production Growth Rate in Europe (2019-2030) & (Tons) Figure 19. Active Pharmaceutical Ingredients (API) Production Growth Rate in China (2019-2030) & (Tons) Figure 20. Active Pharmaceutical Ingredients (API) Production Growth Rate in Japan (2019-2030) & (Tons) Figure 21. Active Pharmaceutical Ingredients (API) Production Growth Rate in India (2019-2030) & (Tons) Figure 22. Global Active Pharmaceutical Ingredients (API) Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 23. Global Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 24. Global Active Pharmaceutical Ingredients (API) Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Figure 25. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in Percentage: 2023 Versus 2030 Figure 26. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2019-2030) Figure 27. Global Active Pharmaceutical Ingredients (API) Sales (2019-2030) & (Tons) Figure 28. Global Active Pharmaceutical Ingredients (API) Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons) Figure 29. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2019-2030) Figure 30. US & Canada Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons) Figure 31. US & Canada Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million) Figure 32. Europe Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons) Figure 33. Europe Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million) Figure 34. China Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons) Figure 35. China Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million) Figure 36. Asia (excluding China) Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons) Figure 37. Asia (excluding China) Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million) Figure 38. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales YoY (2019-2030) & (Tons) Figure 39. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue YoY (2019-2030) & (US$ Million) Figure 40. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2023) Figure 41. The Active Pharmaceutical Ingredients (API) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023 Figure 42. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2023) Figure 43. The Top 5 and 10 Largest Manufacturers of Active Pharmaceutical Ingredients (API) in the World: Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2023 Figure 44. Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 45. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030) Figure 46. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030) Figure 47. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030) Figure 48. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030) Figure 49. US & Canada Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030) Figure 50. US & Canada Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030) Figure 51. US & Canada Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030) Figure 52. US & Canada Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030) Figure 53. US & Canada Active Pharmaceutical Ingredients (API) Revenue Share by Country (2019-2030) Figure 54. US & Canada Active Pharmaceutical Ingredients (API) Sales Share by Country (2019-2030) Figure 55. US Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 56. Canada Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 57. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030) Figure 58. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030) Figure 59. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030) Figure 60. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030) Figure 61. Europe Active Pharmaceutical Ingredients (API) Sales Share by Country (2019-2030) Figure 62. Europe Active Pharmaceutical Ingredients (API) Revenue Share by Country (2019-2030) Figure 63. Germany Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 64. France Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 65. U.K. Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 66. Italy Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 67. Russia Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 68. China Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030) Figure 69. China Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030) Figure 70. China Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030) Figure 71. China Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030) Figure 72. Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030) Figure 73. Asia Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030) Figure 74. Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030) Figure 75. Asia Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030) Figure 76. Asia Active Pharmaceutical Ingredients (API) Revenue Share by Region (2019-2030) Figure 77. Asia Active Pharmaceutical Ingredients (API) Sales Share by Region (2019-2030) Figure 78. Japan Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 79. South Korea Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 80. China Taiwan Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 81. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 82. India Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 83. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2019-2030) Figure 84. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2019-2030) Figure 85. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2019-2030) Figure 86. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2019-2030) Figure 87. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Revenue Share by Country (2019-2030) Figure 88. Middle East, Africa and Latin America Active Pharmaceutical Ingredients (API) Sales Share by Country (2019-2030) Figure 89. Brazil Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 90. Mexico Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 91. Turkey Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 92. Israel Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 93. GCC Countries Active Pharmaceutical Ingredients (API) Revenue (2019-2030) & (US$ Million) Figure 94. Active Pharmaceutical Ingredients (API) Value Chain Figure 95. Active Pharmaceutical Ingredients (API) Production Process Figure 96. Channels of Distribution (Direct Vs Distribution) Figure 97. Bottom-up and Top-down Approaches for This Report Figure 98. Data Triangulation Figure 99. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)